An Aerts

Person

Aerts, An

Person

  1. Ionizing radiation biomarkers in epidemiological studies – An update

    Hall, J., Jeggo, P., West, C., Gomolka, M., Quintens, R., Badie, C., Laurent, O., Aerts, A., Anastasov, N., Azimzadeh, O., Azizova, T., Baatout, S., Baselet, B., Benotmane, R., Blanchardon, E., Gueguen, Y., Haghdoost, S., Harms-Ringhdahl, M., Hess, J., Kreuzer, M., Laurier, D., Macaeva, E., Manning, G., Pernot, E., Ravanat, J-L., Sabatier, L., Tack, K., Tapio, S., Zitzelsberger, H. & Cardis, E., 16 Jan 2017, In: Mutation Research/Reviews in Mutation Research. 771, p. 59-84 26 p.

    Research output: Contribution to journalArticlepeer-review

  2. Preclinical development of 698ga-labelled aptamers for molecular cancer imaging

    Gijs, M., Aerts, A., Impens, N. & Baatout, S., 17 Sep 2015, Liège, Belgium: ULg - Université de Liège. 181 p.

    Research output: ThesisDoctoral thesis

  3. Gallium-68-labelled NOTA-oligonucleotides - an optimized method for their preparation

    Gijs, M., Dammicco, S., Warnier, C., Aerts, A., Impens, N., D’Huyvetter, M., Léonard, M., Baatout, S. & Luxen, A., 1 Feb 2016, In: Journal of Labelled Compounds and Radiopharmaceuticals. 59, 2, p. 63-71 9 p.

    Research output: Contribution to journalArticlepeer-review

  4. Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer

    Gijs, M., Penner, G., Blackler, G. B., Impens, N., Baatout, S., Luxen, A. & Aerts, A., 15 May 2016, In: Pharmaceuticals. 9, 2, 29.

    Research output: Contribution to journalArticlepeer-review

  5. Aptamers as radiopharmaceuticals for nuclear imaging and therapy

    Gijs, M., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 15 Apr 2016, In: Nuclear Medicine and Biology.

    Research output: Contribution to journalArticlepeer-review

  6. Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice

    Gijs, M., Becker, G., Plenevaux, A., Bahri, M. A., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 11 Aug 2016, In: Journal of Nuclear Medicine and Radiation Therapy. 7, 5, 8 p., 1000300.

    Research output: Contribution to journalArticlepeer-review

  7. Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumour

    Geenen, L., Nonnekens, J., Konijnenberg, M. W., Baatout, S., de Jong, M. & Aerts, A., 1 Nov 2021, In: Nuclear Medicine and Biology. 102-103, p. 1-11 11 p.

    Research output: Contribution to journalArticlepeer-review

  8. Translation of radiopharmaceuticals: mouse to man

    Fragoso, P., Rbah-Vidal, L., Aerts, A., van Leeuwen, F. W. B. & Schottelius, M., Jan 2022, Handbook of Nuclear Medicine and Molecular Imaging for Physicists : Radiopharmaceuticals and Clinical Applications. 1e ed. Vol. 3. p. 1-15 15 p.

    Research output: Contribution to report/book/conference proceedingsChapterpeer-review

  9. Gold nanoparticles coated with antibodies lead to ROSdependent apoptotic cell death in non-cancerous human cell lines

    Fichera, O., Van Hoecke, K., Baatout, S., Cardinaels, T., Michiels, C., Lucas, S. & Aerts, A., 31 Dec 2018, Annual Congress of the European Association of Nuclear Medicine October 13 – 17, 2018 Düsseldorf, Germany. Vol. 45. p. S653 1 p. (European Journal of Nuclear Medicine and Molecular Imaging).

    Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

  10. De rol van intercellulaire communicatie in cardiovasculaire aandoeningen na lage stralingsdosis

    Dobbelaere, H. & Aerts, A., Jun 2015, Ghent, Belgium: UGent - Universiteit Gent. 30 p.

    Research output: ThesisMaster's thesis

ID: 39219